IDEXX Laboratories, Inc. (IDXX)
NASDAQ: IDXX · Real-Time Price · USD
417.28
+10.36 (2.55%)
Nov 1, 2024, 4:00 PM EDT - Market closed
IDEXX Laboratories Revenue
IDEXX Laboratories had revenue of $975.54M in the quarter ending September 30, 2024, with 6.56% growth. This brings the company's revenue in the last twelve months to $3.84B, up 7.16% year-over-year. In the year 2023, IDEXX Laboratories had annual revenue of $3.66B with 8.72% growth.
Revenue (ttm)
$3.84B
Revenue Growth
+7.16%
P/S Ratio
8.98
Revenue / Employee
$349,529
Employees
11,000
Market Cap
34.17B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 3.66B | 293.63M | 8.72% |
Dec 31, 2022 | 3.37B | 151.96M | 4.73% |
Dec 31, 2021 | 3.22B | 508.71M | 18.79% |
Dec 31, 2020 | 2.71B | 299.75M | 12.45% |
Dec 31, 2019 | 2.41B | 193.67M | 8.75% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Cardinal Health | 224.45B |
Centene | 146.20B |
Humana | 115.01B |
IQVIA Holdings | 15.32B |
ResMed | 4.81B |
DexCom | 3.95B |
Mettler-Toledo International | 3.75B |
Veeva Systems | 2.57B |
IDXX News
- 2 days ago - IDEXX Laboratories, Inc. (IDXX) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 2 days ago - CORRECTING and REPLACING IDEXX Laboratories Announces Third Quarter Results - Business Wire
- 2 days ago - Idexx Laboratories Adjusts Guidance As Q3 Revenue Growth Slows, Analyst Notes Fewer Veterinary Visits, Looks Towards Long-Term Growth - Benzinga
- 2 days ago - IDEXX laboratories cuts annual revenue forecast for third time as pet clinic visits slow - Reuters
- 2 days ago - IDEXX Laboratories Announces Third Quarter Results - Business Wire
- 4 weeks ago - IDEXX Laboratories to Release 2024 Third Quarter Financial Results - Business Wire
- 2 months ago - IDEXX Laboratories to Present at Morgan Stanley 22nd Annual Global Healthcare Conference - Business Wire
- 2 months ago - IDEXX Laboratories Q2: Headwinds From Low U.S. Clinical Visits - Seeking Alpha